Home SEC Filings Minerva Neurosciences, Inc. (NASDAQ:NERV) Files An 8-K Entry into a Material …
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a …
May 31, 2017 | News Stories
Home SEC Filings Minerva Neurosciences, Inc. (NASDAQ:NERV) Files An 8-K Entry into a Material …
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a …